SAN FRANCISCO, CA -- Oct. 4, 2018 -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today that its laboratory has successfully completed a rigorous validation of ImmunoPrismTM, its comprehensive, quantitative, solid tumor immune-profi...